News for 'Pfizer Inc'

Russian vaccine has efficacy of over 95%: RFID CEO

Russian vaccine has efficacy of over 95%: RFID CEO

Rediff.com24 Nov 2020

In a virtual conference from Moscow, Dmitriev said Sputnik V is not only 'one of the most effective' but also among the 'affordable' vaccines in the world.

US to unveil plans for global distribution of vaccine

US to unveil plans for global distribution of vaccine

Rediff.com2 Jun 2021

In the next two weeks, the United States will detail plans to equitably distribute about 80 million (8 crore) COVID-19 vaccine doses globally without 'political requirements' of those receiving them, Secretary of State Antony Blinken has said.

Modi govt plans to make medicines cheaper

Modi govt plans to make medicines cheaper

Rediff.com24 Jun 2014

The health ministry has formed a committee to consider raising the number of drugs deemed essential and subject to price caps.

Healthcare workers, those above 65 yrs to be given vaccine first: Govt

Healthcare workers, those above 65 yrs to be given vaccine first: Govt

Rediff.com19 Nov 2020

Health Minister Harsh Vardhan said the COVID-19 vaccine will be available in the next few months and it is estimated that by July-August 400-500 million doses will be made available for 25-30 crore people.

US President Biden announces COVID vaccine sharing plan

US President Biden announces COVID vaccine sharing plan

Rediff.com3 Jun 2021

The Biden administration had been under pressure to send the excess COVID-19 vaccines with the US to nations like India, which are facing severe vaccine shortages.

India withdraws policy to cap nonessential pharma prices

India withdraws policy to cap nonessential pharma prices

Rediff.com23 Sep 2014

Ties between India and the United States have been strained in recent years because of trade policies and patent disputes.

Ambani says will provide tech for COVID-19 vaccination drive

Ambani says will provide tech for COVID-19 vaccination drive

Rediff.com15 Dec 2020

As India gets ready to roll out one of the largest vaccine programmes, billionaire Mukesh Ambani on Tuesday said his group is working with authorities to provide technology tools and backbone for mass inoculation against COVID-19. Ambani's telecom venture Jio was rolled out four years back, offering free voice calling and dirt-cheap data. Today, Jio is India's largest telecom operator with over 400 million users, each connected to the internet. At a Facebook event, Ambani said the government's digital push kept the country running even during the pandemic and is now helping in the rollout of one of the largest vaccination programmes.

'Modi must resist US pressure on drug patents'

'Modi must resist US pressure on drug patents'

Rediff.com30 Sep 2014

Western drugmakers, including Pfizer Inc, Novartis AG, Roche Holding AG and Sanofi SA, covet a bigger share of the fast-growing Indian drugs market.

Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine

Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine

Rediff.com28 Aug 2020

Some critics contend that Japan's rush to secure supplies is driven largely by a political desire to show the world it is fully committed to hosting the Games.

Bach projects confidence in Tokyo Games as virus cases surge

Bach projects confidence in Tokyo Games as virus cases surge

Rediff.com16 Nov 2020

Bach's two-day visit to Tokyo is likely to bolster Japan's efforts to stage the Olympics, but will do little to assuage the concerns of a public deeply worried about the spread of the virus.

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Rediff.com10 Mar 2014

The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.

Big blow: India revokes GSK cancer drug patent

Big blow: India revokes GSK cancer drug patent

Rediff.com2 Aug 2013

India's Supreme Court in April rejected a patent for Novartis AG's cancer drug Glivec, saying it was an amended version of a known molecule called imatinib, setting the precedent for more such cases in the country.

UN chief says will take COVID-19 vaccine publicly, calls it his 'moral obligation'

UN chief says will take COVID-19 vaccine publicly, calls it his 'moral obligation'

Rediff.com10 Dec 2020

Guterres reiterated his call for a COVID-19 vaccine to be a global public good available to everywhere and particularly, available in Africa.

Ranbaxy to appeal against quinapril order

Ranbaxy to appeal against quinapril order

Rediff.com30 Mar 2005

Ranbaxy Laboratories will file an appeal against a New Jersey district court order restraining Teva Pharmaceuticals and Ranbaxy Pharmaceuticals Inc from selling RPI's quinapril tablets (5, 10, 20, and 40 mg) on a challenge filed by Pfizer.

Senior directors in India Inc hold more board seats than allowed

Senior directors in India Inc hold more board seats than allowed

Rediff.com5 Aug 2015

Ten months after new Sebi norms set in, some senior directors still hold more board seats than allowed.

Japan denies considering vaccine priority for Olympic athletes

Japan denies considering vaccine priority for Olympic athletes

Rediff.com8 Apr 2021

According to government officials quoted by Kyodo late on Wednesday, Japan has begun looking into the possibility of making sure its Olympic and Paralympic athletes are all vaccinated by the end of June.

Ranbaxy, Cephalon settle patent case

Ranbaxy, Cephalon settle patent case

Rediff.com23 Dec 2005

Close on the heels of a US district court ruling against its patent challenge of Pfizer's Lipitor, Ranbaxy Laboratories Ltd on Friday said it had entered into an out of court settlement with Cephalon Inc

Top pharma M&A deals in 2005

Top pharma M&A deals in 2005

Rediff.com29 Dec 2005

US court convicts Indian-origin fund manager for insider trading

US court convicts Indian-origin fund manager for insider trading

Rediff.com7 Feb 2014

Mathew Martoma, a former SAC Capital portfolio manager, faces 20 years in prison for securities fraud and five years for conspiracy

Low-cost male contraceptive finds no takers

Low-cost male contraceptive finds no takers

Rediff.com5 Apr 2017

It could also ease the burden on the 225 million women in developing countries, says Ari Altstedter.

COVID-19 vaccines likely to have longer shelf life

COVID-19 vaccines likely to have longer shelf life

Rediff.com14 Dec 2020

A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval, reports Sohini Das.

US students who took Covaxin, Sputnik asked to get re-vaccinated

US students who took Covaxin, Sputnik asked to get re-vaccinated

Rediff.com4 Jun 2021

These vaccines have not yet been approved by the World Health Organization

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

'Sevak Project is a health care plan for the villagers and by the villagers'

'Sevak Project is a health care plan for the villagers and by the villagers'

Rediff.com8 Jan 2014

My goal is to implement the Sevak project all over India and make the villages true Gandhian villages -- self sustainable in every way, including health, says Dr Thakor Patel, head of the American Association of Physician of Indian Origin's Public Health Committee. Aziz Haniffa reports

How US companies are helping India fight coronavirus

How US companies are helping India fight coronavirus

Rediff.com16 Apr 2020

A large number of American companies like Google, Uber and IBM are offering their resources to help India successfully fight the battle against the deadly coronavirus pandemic.

Roche's patent pain to be Biocon's gain

Roche's patent pain to be Biocon's gain

Rediff.com19 Aug 2013

Indian firm to soon launch copycat of anti-breast-cancer drug.

« Prev  |